Annual Short Term Debt
$10.35 B
+$7.41 B+252.62%
31 December 2023
Summary:
Pfizer annual short term debt is currently $10.35 billion, with the most recent change of +$7.41 billion (+252.62%) on 31 December 2023. During the last 3 years, it has risen by +$7.64 billion (+282.76%). PFE annual short term debt is now -36.10% below its all-time high of $16.19 billion, reached on 31 December 2019.PFE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$9.70 B
-$2.25 B-18.80%
30 September 2024
Summary:
Pfizer quarterly short term debt is currently $9.70 billion, with the most recent change of -$2.25 billion (-18.80%) on 30 September 2024. Over the past year, it has increased by +$7.15 billion (+280.65%). PFE quarterly short term debt is now -41.61% below its all-time high of $16.61 billion, reached on 29 September 2019.PFE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +252.6% | +280.6% |
| 3 y3 years | +282.8% | +167.3% |
| 5 y5 years | +17.1% | -41.6% |
PFE Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +361.7% | -18.8% | +1425.0% |
| 5 y | 5 years | -36.1% | +361.7% | -41.6% | +1425.0% |
| alltime | all time | -36.1% | +5465.4% | -41.6% | +5117.3% |
Pfizer Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.70 B(-18.8%) |
| June 2024 | - | $11.94 B(+45.1%) |
| Mar 2024 | - | $8.23 B(-20.4%) |
| Dec 2023 | $10.35 B(+252.6%) | $10.35 B(+306.0%) |
| Sept 2023 | - | $2.55 B(-36.1%) |
| June 2023 | - | $3.98 B(-4.9%) |
| Mar 2023 | - | $4.19 B(+42.8%) |
| Dec 2022 | $2.93 B(+30.9%) | $2.93 B(-27.1%) |
| Sept 2022 | - | $4.02 B(-32.5%) |
| June 2022 | - | $5.96 B(+837.9%) |
| Mar 2022 | - | $636.00 M(-71.6%) |
| Dec 2021 | $2.24 B(-17.1%) | $2.24 B(-38.2%) |
| Sept 2021 | - | $3.63 B(-6.7%) |
| June 2021 | - | $3.89 B(-10.7%) |
| Mar 2021 | - | $4.35 B(+61.0%) |
| Dec 2020 | $2.70 B(-83.3%) | $2.70 B(-79.8%) |
| Sept 2020 | - | $13.36 B(+2.1%) |
| June 2020 | - | $13.08 B(-18.3%) |
| Mar 2020 | - | $16.00 B(-1.1%) |
| Dec 2019 | $16.19 B(+83.2%) | $16.19 B(-2.5%) |
| Sept 2019 | - | $16.61 B(+58.1%) |
| June 2019 | - | $10.51 B(+11.6%) |
| Mar 2019 | - | $9.41 B(+6.5%) |
| Dec 2018 | $8.84 B(-11.1%) | $8.84 B(-40.2%) |
| Sept 2018 | - | $14.78 B(+27.6%) |
| June 2018 | - | $11.59 B(+28.7%) |
| Mar 2018 | - | $9.00 B(-9.4%) |
| Dec 2017 | $9.94 B(-6.8%) | $9.94 B(+5.2%) |
| Sept 2017 | - | $9.45 B(-0.7%) |
| June 2017 | - | $9.51 B(+23.9%) |
| Mar 2017 | - | $7.68 B(-28.0%) |
| Dec 2016 | $10.66 B(+5.0%) | $10.66 B(-21.8%) |
| Sept 2016 | - | $13.63 B(-0.7%) |
| June 2016 | - | $13.72 B(+18.9%) |
| Mar 2016 | - | $11.55 B(+13.7%) |
| Dec 2015 | $10.16 B(+97.6%) | $10.16 B(+3.5%) |
| Sept 2015 | - | $9.82 B(+17.0%) |
| June 2015 | - | $8.39 B(+28.1%) |
| Mar 2015 | - | $6.55 B(+27.5%) |
| Dec 2014 | $5.14 B(-14.7%) | $5.14 B(-4.6%) |
| Sept 2014 | - | $5.39 B(-3.1%) |
| June 2014 | - | $5.56 B(-40.3%) |
| Mar 2014 | - | $9.32 B(+54.6%) |
| Dec 2013 | $6.03 B(-6.2%) | $6.03 B(+27.2%) |
| Sept 2013 | - | $4.74 B(-9.1%) |
| June 2013 | - | $5.21 B(-41.4%) |
| Mar 2013 | - | $8.90 B(+38.5%) |
| Dec 2012 | $6.42 B(+60.0%) | $6.42 B(-17.4%) |
| Sept 2012 | - | $7.77 B(+0.9%) |
| June 2012 | - | $7.70 B(+39.4%) |
| Mar 2012 | - | $5.53 B(+37.6%) |
| Dec 2011 | $4.02 B(-28.6%) | $4.02 B(-28.8%) |
| Sept 2011 | - | $5.64 B(-5.9%) |
| June 2011 | - | $5.99 B(-1.7%) |
| Mar 2011 | - | $6.09 B(+8.4%) |
| Dec 2010 | $5.62 B(+2.8%) | $5.62 B(+9.0%) |
| Sept 2010 | - | $5.16 B(-6.4%) |
| June 2010 | - | $5.51 B(-29.1%) |
| Mar 2010 | - | $7.77 B(+42.1%) |
| Dec 2009 | $5.47 B(-41.3%) | $5.47 B(-21.4%) |
| Sept 2009 | - | $6.95 B(-9.0%) |
| June 2009 | - | $7.64 B(+0.4%) |
| Mar 2009 | - | $7.61 B(-18.3%) |
| Dec 2008 | $9.32 B(+60.0%) | $9.32 B(+1.4%) |
| Sept 2008 | - | $9.19 B(-2.7%) |
| June 2008 | - | $9.45 B(+6.1%) |
| Mar 2008 | - | $8.91 B(+52.9%) |
| Dec 2007 | $5.83 B(+139.3%) | $5.83 B(+120.2%) |
| Sept 2007 | - | $2.65 B(+8.8%) |
| June 2007 | - | $2.43 B(-7.8%) |
| Mar 2007 | - | $2.64 B(+8.4%) |
| Dec 2006 | $2.43 B | $2.43 B(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $2.51 B(-33.6%) |
| June 2006 | - | $3.78 B(-25.3%) |
| Mar 2006 | - | $5.06 B(-56.3%) |
| Dec 2005 | $11.59 B(+2.9%) | $11.59 B(+72.2%) |
| Sept 2005 | - | $6.73 B(-7.3%) |
| June 2005 | - | $7.26 B(-45.8%) |
| Mar 2005 | - | $13.40 B(+18.9%) |
| Dec 2004 | $11.27 B(+27.8%) | $11.27 B(+3.8%) |
| Sept 2004 | - | $10.86 B(-11.0%) |
| June 2004 | - | $12.20 B(+14.1%) |
| Mar 2004 | - | $10.69 B(+21.3%) |
| Dec 2003 | $8.82 B(+1.7%) | $8.82 B(-6.2%) |
| Sept 2003 | - | $9.40 B(+14.4%) |
| June 2003 | - | $8.21 B(-11.3%) |
| Mar 2003 | - | $9.27 B(+6.9%) |
| Dec 2002 | $8.67 B(+38.4%) | $8.67 B(-18.9%) |
| Sept 2002 | - | $10.69 B(+27.8%) |
| June 2002 | - | $8.37 B(+8.0%) |
| Mar 2002 | - | $7.75 B(+23.7%) |
| Dec 2001 | $6.26 B(+46.0%) | $6.26 B(-1.6%) |
| Sept 2001 | - | $6.36 B(+37.2%) |
| June 2001 | - | $4.64 B(+17.0%) |
| Mar 2001 | - | $3.96 B(-7.6%) |
| Dec 2000 | $4.29 B(-19.1%) | $4.29 B(-27.7%) |
| Sept 2000 | - | $5.93 B(+7.0%) |
| June 2000 | - | $5.54 B(+49.2%) |
| Mar 2000 | - | $3.72 B(-29.9%) |
| Dec 1999 | $5.30 B(+94.2%) | $5.30 B(-3.4%) |
| Sept 1999 | - | $5.49 B(+11.1%) |
| June 1999 | - | $4.94 B(+14.9%) |
| Mar 1999 | - | $4.30 B(+57.4%) |
| Dec 1998 | $2.73 B(+21.2%) | $2.73 B(-18.5%) |
| Sept 1998 | - | $3.35 B(+29.7%) |
| June 1998 | - | $2.58 B(+2.7%) |
| Mar 1998 | - | $2.52 B(+11.7%) |
| Dec 1997 | $2.25 B(+0.7%) | $2.25 B(-21.0%) |
| Sept 1997 | - | $2.85 B(-4.3%) |
| June 1997 | - | $2.98 B(+15.3%) |
| Mar 1997 | - | $2.58 B(+15.5%) |
| Dec 1996 | $2.23 B(+9.8%) | $2.23 B(-29.2%) |
| Sept 1996 | - | $3.16 B(+24.0%) |
| June 1996 | - | $2.54 B(+8.8%) |
| Mar 1996 | - | $2.34 B(+14.9%) |
| Dec 1995 | $2.04 B(-8.3%) | $2.04 B(-33.2%) |
| Sept 1995 | - | $3.05 B(-0.4%) |
| June 1995 | - | $3.06 B(-1.8%) |
| Mar 1995 | - | $3.12 B(+40.3%) |
| Dec 1994 | $2.22 B(+88.3%) | $2.22 B(+23.6%) |
| Sept 1994 | - | $1.80 B(-2.1%) |
| June 1994 | - | $1.84 B(+21.0%) |
| Mar 1994 | - | $1.52 B(+28.8%) |
| Dec 1993 | $1.18 B(-5.9%) | $1.18 B(-46.9%) |
| Sept 1993 | - | $2.22 B(+2.8%) |
| June 1993 | - | $2.16 B(+17.4%) |
| Mar 1993 | - | $1.84 B(+46.9%) |
| Dec 1992 | $1.25 B(-25.9%) | $1.25 B(-1.6%) |
| Sept 1992 | - | $1.27 B(+20.5%) |
| June 1992 | - | $1.06 B(-18.3%) |
| Mar 1992 | - | $1.29 B(-23.6%) |
| Dec 1991 | $1.69 B(+12.8%) | $1.69 B(+1.4%) |
| Sept 1991 | - | $1.67 B(+7.0%) |
| June 1991 | - | $1.56 B(+23.5%) |
| Mar 1991 | - | $1.26 B(-15.9%) |
| Dec 1990 | $1.50 B(-1.8%) | $1.50 B(+19.2%) |
| Sept 1990 | - | $1.26 B(+15.5%) |
| June 1990 | - | $1.09 B(+10.0%) |
| Mar 1990 | - | $990.20 M(-35.1%) |
| Dec 1989 | $1.53 B(+57.7%) | $1.53 B(+57.7%) |
| Dec 1988 | $967.70 M(+35.4%) | $967.70 M(+35.4%) |
| Dec 1987 | $714.90 M(+163.5%) | $714.90 M(+163.5%) |
| Dec 1986 | $271.30 M(+45.9%) | $271.30 M(+45.9%) |
| Dec 1985 | $185.90 M(-37.8%) | $185.90 M(-37.8%) |
| Dec 1984 | $298.90 M | $298.90 M |
FAQ
- What is Pfizer annual short term debt?
- What is the all time high annual short term debt for Pfizer?
- What is Pfizer annual short term debt year-on-year change?
- What is Pfizer quarterly short term debt?
- What is the all time high quarterly short term debt for Pfizer?
- What is Pfizer quarterly short term debt year-on-year change?
What is Pfizer annual short term debt?
The current annual short term debt of PFE is $10.35 B
What is the all time high annual short term debt for Pfizer?
Pfizer all-time high annual short term debt is $16.19 B
What is Pfizer annual short term debt year-on-year change?
Over the past year, PFE annual short term debt has changed by +$7.41 B (+252.62%)
What is Pfizer quarterly short term debt?
The current quarterly short term debt of PFE is $9.70 B
What is the all time high quarterly short term debt for Pfizer?
Pfizer all-time high quarterly short term debt is $16.61 B
What is Pfizer quarterly short term debt year-on-year change?
Over the past year, PFE quarterly short term debt has changed by +$7.15 B (+280.65%)